These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36164944)

  • 1. Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis.
    Lim C; Kang E; Jung JG; Cheun JH; Kim HK; Lee HB; Moon HG; Han W
    Cancer Res Treat; 2023 Apr; 55(2):562-569. PubMed ID: 36164944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of blue dye alone for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initially node-positive breast cancer.
    Cavalcante FP; Zerwes FP; Souza ABA; Ziegelmann PK; Alcantara R; Cardoso A; Mattar A; Millen EC; Frasson AL
    Eur J Surg Oncol; 2024 Mar; 50(3):107967. PubMed ID: 38262300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotope-Only Localization for Sentinel Lymph Node Biopsy - Medium-Term Oncological Outcomes.
    Micha A; Parvaiz MA; O'Riordan L; MacNeill F; Rusby JE
    Clin Breast Cancer; 2022 Jul; 22(5):e636-e640. PubMed ID: 35396153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study).
    Vidya R; Khosla M; Laws S; Harvey J; Kaushik M; Mullapudi NA; Macmillan D
    Surgeon; 2023 Apr; 21(2):128-134. PubMed ID: 35551871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
    Chen M; Li S; Huang M; Guo J; Huang X; Guo W; Chen L; Lin Y; Jacobs L; Wang C; Fu F
    Breast Cancer Res Treat; 2022 Nov; 196(2):267-277. PubMed ID: 36100784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-assisted carbon nanoparticle suspension mapping versus dual tracer-guided sentinel lymph node biopsy in patients with early breast cancer (ultraCars): phase III randomized clinical trial.
    Zhang L; Cheng M; Lin Y; Zhang J; Shen B; Chen Y; Yang C; Yang M; Zhu T; Gao H; Ji F; Li J; Wang K
    Br J Surg; 2022 Nov; 109(12):1232-1238. PubMed ID: 36074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
    Liu YL; Kuo WL; Lo YF; Tsai HP; Shen SC; Yu CC; Chou HH; Chu CH; Chen SC
    Biomed J; 2022 Apr; 45(2):396-405. PubMed ID: 35562283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial.
    Man V; Suen D; Kwong A
    Ann Surg Oncol; 2023 Jun; 30(6):3237-3244. PubMed ID: 36849573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
    Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
    Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
    Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride for Identification of Sentinel Lymph Nodes During Breast Cancer Surgery: A Clinical Trial.
    Buonomo OC; Materazzo M; Pellicciaro M; Iafrate G; Ielpo B; Rizza S; Pistolese CA; Perretta T; Meucci R; Longo B; Cervelli V; Vanni G
    Anticancer Res; 2023 Feb; 43(2):557-567. PubMed ID: 36697065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings.
    Chavda J; Mishra A; Silodia A; Yadav SK; Sharma DB; Sharma D; Khandare M
    Breast Cancer Res Treat; 2022 May; 193(1):105-110. PubMed ID: 35246773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
    Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
    Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.
    Yang R; Dong C; Jiang T; Zhang X; Zhang F; Fan Z
    Clin Breast Cancer; 2023 Jun; 23(4):408-414. PubMed ID: 36907808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer.
    Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E
    Breast J; 2006; 12(3):199-201. PubMed ID: 16684315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of contrast-enhanced ultrasonography with blue dye for sentinel lymph node detection in clinically negative node breast cancer.
    Wang X; Tang L; Huang W; Cui Z; Hu D; Zhong Z; Wu X
    Arch Gynecol Obstet; 2021 Dec; 304(6):1551-1559. PubMed ID: 34241688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Ersoy YE; Kadioglu H
    Clin Breast Cancer; 2018 Aug; 18(4):e555-e559. PubMed ID: 29429940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.